The FDA gave 510(k) clearance to the first nonpharmacological approach to helping restless legs syndrome patients get better sleep, Sensory Medical said in a May 29 statement. "Relaxis represents the ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Relaxis, the innovative, FDA-cleared, non-drug approach to treating Restless Legs Syndrome (RLS), has been used to help a majority of RLS patients avoid general ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback